MRKR
MRKR
NASDAQ · Biotechnology

Marker Therapeutics Inc

$1.47
+0.01 (+0.68%)
As of Jun 30, 10:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.88M
Net Income
-13,297,166
Gross Margin
Profit Margin
-343.0%
Rev Growth
-26.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.88M 5.29M 3.86M 4.10M
Gross Profit 2.51M 2.67M
Operating Income -14,094,053 -17,307,474 -161,214 -174,270
Net Income -13,297,166 -16,328,898 -155,305 -171,738
Gross Margin 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Rev Growth -26.7% -26.7% +19.6% -4.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 9.32M 9.35M
Total Equity 11.45M 10.87M
D/E Ratio 0.81 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -14,090,477 -18,264,365 -205,551 -243,961
Free Cash Flow -168,121 -167,490